The holiday week may have slowed the markets, but the pot business didn’t take any time off. We’ve got the goods on who missed out in the Alberta deal, and the return of the Friday Flier.
It was a snooze out there today, but we have a new US retail listing and a few developments on the day that we finally see the Canadian marijuana bill passed… sort of. Plus: Abcann Global vs. Invictus MD.
Note: This one was scheduled to be published last night, was delayed in production. This morning, Aleafia Health (ALEF.V) is up $0.10 to $0.90 on 3 million shares, Pascal Biosciences (PAS.V) is up $0.02 to $0.49 on 4 million shares, and Scythian Bioscience (SCYB.V) is down $0.06 to $3.11 on 75k shares.
The slightest of oil bumps got the Canadian mid-caps spending like drunken sailors, the market hates it. Meanwhile, mining deals are so cheap that flush companies are making all-cash offers at 50% premium.
Two new pot deals launched on a down day, so we’re having a look at what’s working and what isn’t in this extended trip.